Оксим инденохиноксалинона IQ-1 как перспективный агент для разработки лекарственных препаратов

Bibliographic Details
Parent link:Курзина, И. А. (химик ; 1972-). Перспективы развития фундаментальных наук=Prospects of Fundamental Sciences Development: сборник научных трудов XXI Международной конференции студентов, аспирантов и молодых ученых, г. Томск, 23-26 апреля 2024 г..— .— Томск: Изд-во ТПУ
Т. 2 : Химия.— 2024.— С. 116-118
Main Author: Коврижина А. Р. Анастасия Руслановна
Corporate Author: Национальный исследовательский Томский политехнический университет (570)
Other Authors: Лесина Ю. А. Юлия Александровна (727), Андрианов В. В., Хлебников А. И. Андрей Иванович
Summary:Заглавие с экрана
In the present study, we synthesized and investigated the 11H-indeno[1,2-b]quinoxalin-11-one oxime (IQ-1) as a promising pharmacological substance with anti-ischemic, antihypertensive, and hypolipidemic properties. An experimental study of nitric oxide (NO) formation in vivo was undertaken with the use of EPR methodology. A mechanism for the NO release by the enzymatic oxidation of IQ-1 was proposed. We have developed a technological scheme for the IQ-1 synthesis based on low-cost starting materials
Текстовый файл
Language:Russian
Published: 2024
Subjects:
Online Access:http://earchive.tpu.ru/handle/11683/80590
Format: Electronic Book Chapter
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=674025
Description
Summary:Заглавие с экрана
In the present study, we synthesized and investigated the 11H-indeno[1,2-b]quinoxalin-11-one oxime (IQ-1) as a promising pharmacological substance with anti-ischemic, antihypertensive, and hypolipidemic properties. An experimental study of nitric oxide (NO) formation in vivo was undertaken with the use of EPR methodology. A mechanism for the NO release by the enzymatic oxidation of IQ-1 was proposed. We have developed a technological scheme for the IQ-1 synthesis based on low-cost starting materials
Текстовый файл